在胃癌进展和下游调控网络中,PRKD3对细胞周期的影响
Shuaiyang Wang1,2, Bei Xie3, Haohua Deng1,2
1Department of Clinical Laboratory Center, Lanzhou University Second Hospital, Lanzhou, 730000, Gansu, China.
Medical oncology (Northwood, London, England)
|March 25, 2025
概括
蛋白激酶D3 (PRKD3) 在胃癌 (GC) 中过度表达,导致瘤进展和不良患者结果. 抑制PRKD3可减少GC恶性瘤,并为这种疾病提供潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 蛋白激酶D3 (PRKD3) 与瘤发育有关,但其在胃癌 (GC) 和细胞循环调节中的具体作用尚不清楚.
- 了解PRKD3的功能对于开发向的GC疗法至关重要.
研究的目的:
- 研究PRKD3在胃癌进展中的作用及其对细胞周期的影响.
- 确定潜在的治疗策略,针对GC中的PRKD3.
主要方法:
- 在GC组织中对PRKD3表达的生物信息分析.
- 在体外实验中使用GC细胞系来评估PRKD3敲击对恶性瘤的影响.
- 蛋白质组和西方斑点分析以阐明PRKD3的分子机制.
主要成果:
- 在GC组织中,PRKD3显著过度表达,与患者预后不佳相关.
- 镇压PRKD3抑制了GC细胞的增殖,迁移和入侵,诱导G2/M阶段停止.
- 蛋白质组分析显示,PRKD3影响细胞周期蛋白 (CDK1,CyclinB1,CHK1,PLK1) 和信号通路 (FoxO,p53).
结论:
- 过度表达PRKD3与激进的GC行为和不良结果有关.
- 向PRKD3为胃癌治疗提供了一个有希望的治疗途径.
更多相关视频
相关概念视频
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Molecular Factors Affecting Cell Division
2.9K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
2.9K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


